Login / Signup
Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to reassess? Authors' reply.
Vipul Jairath
C Ma
Brian G Feagan
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
risk factors
human health
risk assessment